- Abrams E, Matheson P, Thomas P, Thea D, Krasinski K, Lambert G, et al. Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. Pediatrics 1995; 96: 451–8.
- Centers for Disease Control and Prevention. Recommendations on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR 1994: 43.
- Marczyńska M, Szczepańska-Putz M, Sarnecki M. Model opieki nad dziećmi matek zakażonych HIV. Pediatria Polska 1997; 10: 955–8.
- Marczyńska M, Szczepańska-Putz M, Sarnecki M. Zasady postepowania z noworodkiem i niemowleciem matki zakazonej HIV. Problemy HIV i AIDS 1997; 3: 21–3.
- Johnson M. 3TC pharmacokinetics in women and their progeny. Proceedings of the XI International Conference on AIDS; 1996, Vancouver. London: MediTech Media Ltd, 18, 1996.
- Centers for Disease Control and Prevention. Public Health Service Task Force Recommendations for the Use of Antiretroviral Drugs in Pregnant Women Infected with HIV-1 for maternal Health and for Reducing Perinatal HIV-1 Transmission in the United States. MMWR 1998; 47: 1–29.
- Mirochnick M, Sullivan J, Gagnier P. Safety and pharmacockineticks of nevirapine in neonates born to HIV-1 infected women. Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections: 198, Washington, 1997.
- Progress in the prevention of perinatal transmission. Abstracts of the XI International Conference on AIDS: 17–18, Vancouver. London: MediTech Media Ltd, 17, 1996.
- Lorenzi P, Chaves J, Kaiser L, Hirschel B, Perrin L, Yerly S. Safety of combined antiretroviral therapies with or without protease inhibitors in pregnant HIV-infected women and their offspring. 12th World AIDS Conference Geneva. Abstract Conference Suplement: 27, July 1998.
- Centers for Disease Control and Prevention. US Public Health Service Recommendations for Human Immunodeficiency Virus Counseling and Voluntary Testing for Pregnant Women. MMWR 1995; 44: 7.
- Carmichael C: Preventing perinatal HIV transmission: zidovudine use during pregnancy. Am. Family Physician 1997; 55: 171–4.
- Inglot M., Ryszkowska M.: Czynniki ryzyka odmatczynych zakażeń HIV. Problemy HIV i AIDS 1997; 3: 11–14.
- Mandelbrot L, et al. Perinatal HIV transmission: Interaction between zidovudine prophylaxis and mode of delivery in the French perinatal cohort. JAMA 1998; 280: 55–60.
- Mok J, Cooper S. The needs of children whose mothers have HIV infection. Arch Dis Child 1997; 77: 483–7.
Vertical Transmission of HIV-1 in Poland
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.